The World Health Organization was seeking clarification from New Delhi on whether a cough syrup linked to deaths in India has been exported to other countries, the global health agency told Reuters on Wednesday.
The WHO said it will assess the need for a Global Medical Products Alert on Coldrif syrup once it receives official confirmation from the Indian authorities.
At least 17 children younger than five years old have died in India in the past month after consuming cough medicine that contained the toxic compound diethylene glycol in quantities nearly 500 times the permissible limit, officials say. (Reporting by Jennifer Rigby; Writing by Sudipto Ganguly; Editing by Hugh Lawson)
Oman Observer is now on the WhatsApp channel. Click here
